Page last updated: 2024-11-05

methyl 4-aminobenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID12082
CHEMBL ID1927048
SCHEMBL ID42732
MeSH IDM0184234

Synonyms (66)

Synonym
4-14-00-01128 (beilstein handbook reference)
BB 0263172
p-aminobenzoic acid methyl ester
p-(methoxycarbonyl)aniline
methyl 4-aminobenzoate ,
nsc3783
619-45-4
nsc-3783
4-aminobenzoic acid methyl ester
methyl p-aminobenzoate
4-(methoxycarbonyl)aniline
methyl aniline-4-carboxylate
benzoic acid, p-amino-, methyl ester
benzoic acid, 4-amino-, methyl ester
AE-848/32195053
brn 0775913
nsc 3783
4-(carbomethoxyl)aniline
ai3-02437
4-carbomethoxyaniline
einecs 210-598-7
p-aminobenzoic acid, methyl ester
inchi=1/c8h9no2/c1-11-8(10)6-2-4-7(9)5-3-6/h2-5h,9h2,1h
GHL.PD_MITSCHER_LEG0.22
methyl 4-aminobenzoate, 98%
STK397390
A0510
HMS1732M08
AKOS000119024
A833497
4-amino-benzoic acid methyl ester
CHEMBL1927048
FT-0617560
AM20040876
SCHEMBL42732
4-amino benzoic acid methyl ester
methyl 4-amino-benzoate
methyl 4-aminobenzenecarboxylate
4-amino-benzoic acid methylester
methyl 4aminobenzoate
4-methoxycarbonylaniline
4-carbomethoxy aniline
4-aminobenzoic methyl ester
methyl-4-amino-benzoate
methyl-4-aminobenzoate
methyl4-aminobenzoate
DTXSID7060704
W-105072
TS-01993
methyl ester of 4-aminobenzoic acid
4-(carbomethoxy)aniline
methyl ester of p-aminobenzoic acid
4-amino methyl benzoate
mfcd00007891
F3377-0763
CS-W009283
SY017810
BCP25649
doi:10.14272/lzxxnpoyqclxrs-uhfffaoysa-n.1
10.14272/LZXXNPOYQCLXRS-UHFFFAOYSA-N.1
Q63409584
methyl-p-aminobenzoate
methyl p-amino benzoate
EN300-16169
GC4GA4E73E
Z54178705
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID635351Increase in BMP2-mediated osteoblastogenesis in mouse C2C12 cells assessed as increase in BMP6 mRNA level at 10 uM by SYBR-based RT-PCR2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID635354Increase in BMP2-mediated osteoblastogenesis in mouse C2C12 cells assessed as increase in OCN mRNA level at 10 uM by SYBR-based RT-PCR2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID635348Increase in human recombinant BMP2-mediated osteoblastogenesis in mouse C2C12 cells assessed as induction of alkaline phosphatase activity after 6 days2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID635350Increase in BMP2-mediated osteoblastogenesis in mouse C2C12 cells assessed as increase in BMP4 mRNA level at 10 uM by SYBR-based RT-PCR2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID635353Increase in BMP2-mediated osteoblastogenesis in mouse C2C12 cells assessed as increase in BMP9 mRNA level at 10 uM by SYBR-based RT-PCR2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID635352Increase in BMP2-mediated osteoblastogenesis in mouse C2C12 cells assessed as increase in BMP7 mRNA level at 10 uM by SYBR-based RT-PCR2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID635357Induction of alkaline phosphatase activity in mouse C2C12 cells2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID1146772Dissociation constant, pKa of the compound1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
AID635349Increase in BMP2-mediated osteoblastogenesis in mouse C2C12 cells assessed as increase in BMP2 mRNA level at 10 uM by SYBR-based RT-PCR2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
AID1146770Competitive inhibition of Escherichia coli B H2-pteroate synthetase assessed as decrease in H2-pteroate formation using [7-14C]-PABA as substrate treated with enzyme for 10 mins prior to substrate challenge for 40 mins by radioassay method1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.10 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index48.61 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]